A Study to Assess APO866 for the Treatment of Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Study to Compare Two Formulations of CP-675,206 Monoclonal Antibody
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Recombinant Vaccinia Virus to Treat Malignant Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.
- Status
- COMPLETED
- Phase
- PHASE1
Imatinib in Adult Patients With Metastatic Ocular Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Interleukin-2 With Sorafenib (BAY 43-9006) for Unresectable or Metastatic Clear Cell Renal Carcinoma (RCC) and Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Lenalidomide and Dacarbazine (DTIC) in Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Abraxane and Temodar Plus Genasense in Advanced Melanoma
- Status
- UNKNOWN
- Phase
- PHASE1
Melanoma Inhibitory Activity (MIA): A Serological Marker for Metastatic Uveal Melanoma
- Status
- UNKNOWN
- Phase
- N/A
Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Targeted Intervention for Melanoma Prevention
- Status
- COMPLETED
- Phase
- NA
Sentinel Lymph Node (SLN) Biopsy for Conjunctival/Eyelid Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
131-I-TM-601 Study in Adults With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Rollover Study for Patients Who Received Tremelimumab in Other Protocols, to Allow the Patients Access to Tremelimumab Until This Agent Becomes Commercially Available or Development is Discontinued.
- Status
- COMPLETED
- Phase
- PHASE2
Characterization of the Melanoma-Specific Immune Response
- Status
- RECRUITING
- Phase
- N/A
Immunization of Disease-Free Melanoma Patients With Different HLA-A2 Peptides
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma
- Status
- COMPLETED
- Phase
- PHASE1